By Brian Lee | February 5, 2024
Chief Judge Elizabeth Wolford of U.S. District Court, Western District in Rochester wrote that the plaintiffs failed to present a viable claim under the Sherman Act.
New York Law Journal | Analysis
By Jeanna M. Wacker, Tasha Gerasimow and Nick Johnston | January 12, 2024
This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.
By Brian Lee | December 28, 2023
The lawsuit is by the towns of Babylon of Suffolk County, and Brookhaven, Hempstead, Huntington, Islip, North Hempstead, Oyster Bay, Ramapo and Smithtown of Nassau County, which in total are populated by more than 3 million people.
By Amanda Bronstad | December 18, 2023
Kenvue, formerly Johnson & Johnson Consumer, manufacturer of Tylenol, said it planned to move for dismissal of the lawsuits after U.S. District Judge Denise Cote found all five of plaintiffs' general causation experts inadmissible.
By Brian Lee | December 14, 2023
An attorney for a New York consumer-protection advocacy coalition asked lawmakers to advance a fifth proposal, the Consumer and Small Business Protection Act, which didn't make it out of committee.
New York Law Journal | Analysis
By Karen Hoffman Lent and Kenneth Schwartz | December 11, 2023
Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
By Jimmy Hoover | December 4, 2023
High court members note opioid victims' broad support for the deal despite the federal government's objection.
By Adolfo Pesquera | November 21, 2023
The attorney general alleges in the complaints that, "Pfizer knowingly distributed Quillivant to children on Medicaid despite the drug's pattern of failing quality control tests due to flawed manufacturing practices."
By Emily Saul | September 14, 2023
Hikma Pharmaceuticals claimed Lloyd's of London has breached a policy to provide coverage given proper notice.
By Emily Saul | August 31, 2023
Manhattan Supreme Court Justice Robert Reed in March dismissed a similar lawsuit filed by the AG's Office, finding the enforcement agency had "artificially limited" the market by failing to allege CVS had engaged in any activity to prevent competition.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
U.S. District Court for the Northern District of CaliforniaThe current term of office for United States Magistrate Judge Susan van Keulen in...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS